Suven Life Sciences soars on getting nod to raise funds up to $100 million

26 Sep 2014 Evaluate

Suven Life Sciences is currently trading at Rs. 182.00, up by 11.45 points or 6.71% from its previous closing of Rs. 170.55 on the BSE.

The scrip opened at Rs. 170.55 and has touched a high and low of Rs. 184.40 and Rs. 163.45 respectively. So far 340687 shares were traded on the counter.

The BSE group 'B ' stock of face value Rs. 1 has touched a 52 week high of Rs. 229.80 on 08-Sep-2014 and a 52 week low of Rs. 41.20 on 30-Sep-2013.

Last one week high and low of the scrip stood at Rs. 209.10 and Rs. 169.95 respectively. The current market cap of the company is Rs. 2094.74 crore.

The promoters holding in the company stood at 64.76 % while Institutions and Non-Institutions held 1.42 % and 33.82 % respectively.

Suven Life Sciences has received an approval for raising of funds not exceeding $100 million or its equivalent of any other Foreign/ Indian currencies by way of issue of securities to QIPs/ FCCBs/ other modes in accordance with SEBI guidelines and subject to necessary approvals from statutory authorities as may be required. The board of directors at their meeting held on September 22, 2014 has approved for the same.

Suven Life Science is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products, which are first in class or best in class CNS therapies through the use of GPCR targets.

Suven Life Sciences Share Price

163.90 -2.15 (-1.29%)
29-Dec-2025 15:40 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.30
Dr. Reddys Lab 1268.00
Cipla 1493.10
Zydus Lifesciences 904.25
Lupin 2078.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×